Lanean...
Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells
Pancreatic cancer (PanC) is one of the most lethal malignancies, and resistance towards gemcitabine, the front-line chemotherapy, is the main cause for dismal rate of survival in PanC patients; overcoming this resistance remains a major challenge to treat this deadly malignancy. Whereas several mole...
Gorde:
| Argitaratua izan da: | Int J Oncol |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356502/ https://ncbi.nlm.nih.gov/pubmed/25672620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.2885 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|